gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
electroCore, Inc. (ECOR)
Last electrocore, inc. earnings: 3/23 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
ROCKAWAY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer-reviewed study in Frontiers in Neurology demonstrating the effectiveness of gammaCore® non-invasive vagus nerve stimulation (nVNS) in reducing persistent symptoms associated with mild traumatic brain injury (mTBI). “The CDC reports approximately 2.5 million emergency department visits each year in the United States for traumatic brain injury, with 70–90% considered mild,” said Peter Staats, MD, MBA, Chief Medical Officer of electroCore. “Until now, treatment has largely been limited to supportive care. These findings highlight an important potential advance—not only for the general population, but also for the U.S. military, where 1–2% of service members experience a mild TBI annually.” The article, entitled “Non-invasive vagus nerve stimulation is associated with the reduction in persistent p
Show less
Read more
Impact Snapshot
Event Time:
ECOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ECOR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ECOR alerts
High impacting electroCore, Inc. news events
Weekly update
A roundup of the hottest topics
ECOR
News
- electroCore (NASDAQ:ECOR) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force AirmenGlobeNewswire
- electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewswire
- electroCore Announces Third Quarter 2025 Financial ResultsGlobeNewswire
- electroCore (NASDAQ:ECOR) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
ECOR
Earnings
- 11/5/25 - Miss
ECOR
Sec Filings
- 12/3/25 - Form 4
- 11/14/25 - Form 4
- 11/13/25 - Form SCHEDULE
- ECOR's page on the SEC website